A novel immunotherapy for relapsed/refractory acute lymphoblastic leukemia (ALL)

被引：0
|
作者：
Saini, Uksha
Hixon, Julie
Rodrigues, Gisele
Foley, Christopher
Chibas, Leniher Castan
Hamilton, Ross
Li, Wenqing
Schafer, Eric S.
Rheingold, Susan
Heffernan, Michael
Breitfeld, Philip
Durum, Scott
Varadhachary, Atul
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-5664
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5664
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Venetoclax and Navitoclax in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
    Alexander, Thomas
    Lacayo, Norman J.
    Pullarkat, Vinod A.
    Jabbour, Elias J.
    Khaw, Seong Lin
    Mullighan, Charles G.
    Bajel, Ashish
    Leonard, Jessica
    Norris, Robin
    Rubnitz, Jeffrey
    Vear, Susan I.
    Schmidt, Michelle
    Tong, Bo
    Zhou, Ying
    Ross, Jeremy A.
    Rosenwinkel, Lindsey
    Jacobson, Amanda
    Kim, Su Young
    Stock, Wendy
    BLOOD, 2018, 132
  • [22] Novel Salvage Therapies Are Highly Effective in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) with Philadelphia (Ph)-like Fusions
    Aldoss, Ibrahim
    Yang, Dongyun
    Afkhami, Michelle
    Gu, Zhaohui
    Mokhtari, Sally
    Shahani, Shilpa
    Agrawal, Vaibhav
    Pourhassan, Hoda
    Koller, Paul B.
    Tomasian, Vanina
    Telatar, Milhan
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Ali, Haris
    Aribi, Ahmed
    Sandhu, Karamjeet S.
    Arslan, Shukaib
    Ball, Brian J.
    Otoukesh, Salman
    Amanam, Idoroenyi
    Artz, Andrew S.
    Becker, Pamela S.
    Stewart, Forrest M.
    Curtin, Peter T.
    Pillai, Raju
    Smith, Eileen P.
    Marcucci, Guido
    Stein, Anthony S.
    Forman, Stephen J.
    Nakamura, Ryotaro
    Pullarkat, Vinod A.
    BLOOD, 2022, 140 : 6020 - 6022
  • [23] Editorial: Immunotherapy in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL)
    Jamy, Omer
    Zhou, Fuling
    Zeidner, Joshua
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] TREATMENT OF RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    HENZE, G
    BLUT, 1986, 53 (03): : 145 - 146
  • [25] Immunopharmacodynamic response to blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL)
    Schub, A.
    Naegele, V
    Zugmaier, G.
    Brandl, C.
    Hijazi, Y.
    Topp, M. S.
    Kufer, P.
    Wolf, A.
    Klinger, M.
    ONKOLOGIE, 2013, 36 : 183 - 183
  • [26] EVOLUTION OF THE HISTONE CODE IN RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Bhatla, Teena
    Wang, Jinhua
    Morrison, Debra
    Jones, Courtney
    Raetz, Elizabeth
    Burke, Michael
    Brown, Patrick
    Loh, Mignon
    Hunger, Stephen
    Carroll, William
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S40 - S40
  • [27] The INK locus in relapsed childhood acute lymphoblastic leukemia(ALL).
    Carter, TL
    Watt, PM
    Reaman, GH
    Kees, UR
    BLOOD, 2002, 100 (11) : 201B - 201B
  • [28] GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia
    Camera, A
    Annino, L
    Chiurazzi, F
    Fazi, P
    Cascavilla, N
    Fabbiano, F
    Marmont, F
    Di Raimondo, F
    Recchia, A
    Vignetti, M
    Rotoli, B
    Mandelli, F
    HAEMATOLOGICA, 2004, 89 (02) : 145 - 153
  • [29] Immunopharmacodynamic response to blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL).
    Schub, Andrea
    Naegele, Virginie
    Zugmaier, Gerhard
    Brandl, Christian
    Hijazi, Youssef
    Topp, Max S.
    Kufer, Peter
    Wolf, Andreas
    Klinger, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] Phase II study of liposomal vincristine (lipoV) in relapsed or refractory adult acute lymphoblastic leukemia (ALL).
    Thomas, DA
    Sarris, A
    O'Brien, S
    Cortes, J
    Giles, FJ
    Faderl, S
    Keating, MJ
    Burge, C
    Cabanillas, F
    Kantarjian, H
    BLOOD, 1999, 94 (10) : 238B - 238B
12345